UA67227U - Способ прогнозирования хода острого инфекционного миокардита у детей - Google Patents
Способ прогнозирования хода острого инфекционного миокардита у детей Download PDFInfo
- Publication number
- UA67227U UA67227U UAU201108437U UAU201108437U UA67227U UA 67227 U UA67227 U UA 67227U UA U201108437 U UAU201108437 U UA U201108437U UA U201108437 U UAU201108437 U UA U201108437U UA 67227 U UA67227 U UA 67227U
- Authority
- UA
- Ukraine
- Prior art keywords
- disease
- children
- course
- heart
- patient
- Prior art date
Links
- 230000001154 acute effect Effects 0.000 title abstract description 6
- 206010052768 Infectious myocarditis Diseases 0.000 title abstract description 4
- 238000000034 method Methods 0.000 title abstract description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 23
- 201000010099 disease Diseases 0.000 abstract description 21
- 238000011160 research Methods 0.000 abstract 1
- 208000001871 Tachycardia Diseases 0.000 description 11
- 208000015181 infectious disease Diseases 0.000 description 11
- 230000006794 tachycardia Effects 0.000 description 11
- 238000002592 echocardiography Methods 0.000 description 9
- 230000007170 pathology Effects 0.000 description 9
- 230000035935 pregnancy Effects 0.000 description 9
- 208000018672 Dilatation Diseases 0.000 description 7
- 208000000059 Dyspnea Diseases 0.000 description 6
- 206010013975 Dyspnoeas Diseases 0.000 description 6
- 238000003745 diagnosis Methods 0.000 description 6
- 230000003287 optical effect Effects 0.000 description 6
- 208000013220 shortness of breath Diseases 0.000 description 6
- 206010009152 Chronic tonsillitis Diseases 0.000 description 5
- 206010044008 tonsillitis Diseases 0.000 description 5
- 230000003313 weakening effect Effects 0.000 description 5
- 206010019842 Hepatomegaly Diseases 0.000 description 3
- 208000009525 Myocarditis Diseases 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 206010024378 leukocytosis Diseases 0.000 description 3
- 206010003671 Atrioventricular Block Diseases 0.000 description 2
- 206010064550 Myocarditis post infection Diseases 0.000 description 2
- 208000025747 Rheumatic disease Diseases 0.000 description 2
- 238000009534 blood test Methods 0.000 description 2
- 230000001684 chronic effect Effects 0.000 description 2
- 238000002565 electrocardiography Methods 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 201000007529 rheumatic myocarditis Diseases 0.000 description 2
- 230000033764 rhythmic process Effects 0.000 description 2
- 238000011272 standard treatment Methods 0.000 description 2
- 238000010967 transthoracic echocardiography Methods 0.000 description 2
- 241000566113 Branta sandvicensis Species 0.000 description 1
- 208000031229 Cardiomyopathies Diseases 0.000 description 1
- 206010062746 Carditis Diseases 0.000 description 1
- 206010019280 Heart failures Diseases 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 201000001943 Tricuspid Valve Insufficiency Diseases 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 210000001765 aortic valve Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 238000004159 blood analysis Methods 0.000 description 1
- 230000000747 cardiac effect Effects 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 201000006549 dyspepsia Diseases 0.000 description 1
- 230000002169 extracardiac Effects 0.000 description 1
- 208000019622 heart disease Diseases 0.000 description 1
- 208000024798 heartburn Diseases 0.000 description 1
- 230000001900 immune effect Effects 0.000 description 1
- 230000002458 infectious effect Effects 0.000 description 1
- 208000021646 inflammation of heart layer Diseases 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 230000008506 pathogenesis Effects 0.000 description 1
- 208000008494 pericarditis Diseases 0.000 description 1
- 238000004393 prognosis Methods 0.000 description 1
- 230000000552 rheumatic effect Effects 0.000 description 1
- 210000000513 rotator cuff Anatomy 0.000 description 1
- 235000014347 soups Nutrition 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000002861 ventricular Effects 0.000 description 1
Landscapes
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
Способ прогнозирования хода острого инфекционного миокардита у детей включает проведение пациенту общепринятых лабораторных и инструментальных исследований. Фиксируют и оценивают 20 клинико-инструментальных признаков путем поиска их сочетаний - дифференциальных прогностических детерминант, характерных для продолжения заболевания. При наличии хотя бы одной из дифференциальных прогностических детерминант, прогнозируют продолжение заболевания в будущем в течение более трех месяцев.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| UAU201108437U UA67227U (ru) | 2011-07-05 | 2011-07-05 | Способ прогнозирования хода острого инфекционного миокардита у детей |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| UAU201108437U UA67227U (ru) | 2011-07-05 | 2011-07-05 | Способ прогнозирования хода острого инфекционного миокардита у детей |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| UA67227U true UA67227U (ru) | 2012-02-10 |
Family
ID=52288076
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| UAU201108437U UA67227U (ru) | 2011-07-05 | 2011-07-05 | Способ прогнозирования хода острого инфекционного миокардита у детей |
Country Status (1)
| Country | Link |
|---|---|
| UA (1) | UA67227U (ru) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2539990C2 (ru) * | 2012-11-15 | 2015-01-27 | Федеральное бюджетное учреждение науки Центральный научно-исследовательский институт эпидемиологии Роспотребнадзора | Способ комплексной оценки показаний к назначению кардиометаболической терапии при инфекционных заболеваниях |
| RU2714178C2 (ru) * | 2017-09-27 | 2020-02-12 | Татьяна Александровна Руженцова | Способ оценки степени риска неблагоприятных исходов инфекционных поражений миокарда у детей и подростков |
-
2011
- 2011-07-05 UA UAU201108437U patent/UA67227U/ru unknown
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2539990C2 (ru) * | 2012-11-15 | 2015-01-27 | Федеральное бюджетное учреждение науки Центральный научно-исследовательский институт эпидемиологии Роспотребнадзора | Способ комплексной оценки показаний к назначению кардиометаболической терапии при инфекционных заболеваниях |
| RU2714178C2 (ru) * | 2017-09-27 | 2020-02-12 | Татьяна Александровна Руженцова | Способ оценки степени риска неблагоприятных исходов инфекционных поражений миокарда у детей и подростков |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Sandoval et al. | Cardiac troponin for assessment of myocardial injury in COVID-19: JACC review topic of the week | |
| Kannel et al. | Factors of risk in the development of coronary heart disease—six-year follow-up experience: the Framingham Study | |
| Maron et al. | Contemporary definitions and classification of the cardiomyopathies: an American Heart Association scientific statement from the council on clinical cardiology, heart failure and transplantation committee; quality of care and outcomes research and functional genomics and translational biology interdisciplinary working groups; and council on epidemiology and prevention | |
| Ashton et al. | The incidence of perioperative myocardial infarction in men undergoing noncardiac surgery | |
| Ambrosy et al. | The global health and economic burden of hospitalizations for heart failure: lessons learned from hospitalized heart failure registries | |
| Semsarian et al. | New perspectives on the prevalence of hypertrophic cardiomyopathy | |
| Daubeney et al. | Clinical features and outcomes of childhood dilated cardiomyopathy: results from a national population-based study | |
| Pagidipati et al. | Estimating deaths from cardiovascular disease: a review of global methodologies of mortality measurement | |
| Diakos et al. | Myocardial atrophy and chronic mechanical unloading of the failing human heart: implications for cardiac assist device–induced myocardial recovery | |
| Verwerft et al. | Heart failure with preserved ejection fraction: relevance of a dedicated dyspnoea clinic | |
| Lee et al. | Association of cardiac hemodynamic factors with severity of white matter hyperintensities in chronic valvular heart disease | |
| Heuvelman et al. | Clinical course of patients diagnosed with severe aortic stenosis in the Rotterdam area: insights from the AVARIJN study | |
| Musumeci et al. | Left ventricular remodeling in hypertrophic cardiomyopathy: an overview of current knowledge | |
| Mauro et al. | Acute Heart Failure: Diagnostic–Therapeutic Pathways and Preventive Strategies—A Real-World Clinician’s Guide | |
| Kraoua et al. | Molecular autopsy and clinical family screening in a case of sudden cardiac death reveals ACTN2 mutation related to hypertrophic/dilated cardiomyopathy and a novel LZTR1 variant associated with Noonan syndrome | |
| UA67227U (ru) | Способ прогнозирования хода острого инфекционного миокардита у детей | |
| Ai et al. | Ageing and Alzheimer’s disease: Application of artificial intelligence in mechanistic studies, diagnosis, and drug development | |
| Tudoran et al. | Correspondence between aortic and arterial stiffness, and diastolic dysfunction in apparently healthy female patients with post-acute COVID-19 syndrome | |
| Bombardini et al. | Hemodynamic heterogeneity of reduced cardiac reserve unmasked by volumetric exercise echocardiography | |
| Hui et al. | Discordant aortic valve morphology in monozygotic twins: A clinical case series | |
| Blagova et al. | Different phenotypes of sarcomeric MYBPC3-cardiomyopathy in the same family: Hypertrophic, left ventricular noncompaction and restrictive phenotypes (in association with sarcoidosis) | |
| Gawinski et al. | Assessment of In-Hospital Mortality and Its Risk Factors in Patients with Myocardial Infarction Considering the Logistical Aspects of the Treatment Process—A Single-Center, Retrospective, Observational Study | |
| Davis et al. | Detecting pathogen exposure during the non-symptomatic incubation period using physiological data: proof of concept in non-human primates | |
| Cazalbou et al. | Frailty in Older Patients with Transthyretin Cardiac Amyloidosis | |
| Iacobescu et al. | Diagnostic and Prognostic Role of Circulating microRNAs in Patients with Coronary Artery Disease—Impact on Left Ventricle and Arterial Function |